Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2019 Dec 9;124(4):326–332. doi: 10.1016/j.anai.2019.12.001

Figure 2. Response to dupilumab in a patient with AERD.

Figure 2.

Representative sinus CT scan images are shown for a patient with AERD prior to starting treatment with dupilumab (left) and again after four months of every-other-week dupilumab treatment (right).